Abstract
12-O-Acetylazedarachin B (1), isolated from the fruit extract of Melia azedarach , exhibited potent cytotoxicity against leukemia (HL-60) (IC 50 0.016μM) and stomach (AZ521) (IC50 0.035μM) cancer cell lines. Upon assessing the apoptosis-inducing activity in HL-60 cells, compound 1 exhibited induction of apoptosis detected by the observation of membrane phospholipid exposure and DNA fragmentation in flow cytometry. Western blot analysis showed that 1 markedly reduced the levels of procaspases-3, 8, and 9, while being increased the levels of cleaved caspases-3, 8, and 9. In addition, compound 1 increased significantly Bax/Bcl-2 ratio. These results suggested that 1 induced apoptotic cell death in HL-60 via both mitochondrial and death receptor-mediated pathways. Therefore, compound 1 may be promising lead compound for developing an effective drug for treatment of leukemia. Flow cytometric analysis suggested that the cytotoxicity of 1 against AZ521 is due to inducing apoptosis as well as necrosis with the latter predominated. © 2013 The Pharmaceutical Society of Japan.
Author supplied keywords
Cite
CITATION STYLE
Kikuchi, T., Pan, X., Ishii, K., Nakamura, Y., Ogihara, E., Koike, K., … Akihisa, T. (2013). Cytotoxic and apoptosis-inducing activities of 12-O-acetylazedarachin B from the fruits of Melia azedarach in human cancer cell lines. Biological and Pharmaceutical Bulletin, 36(1), 135–139. https://doi.org/10.1248/bpb.b12-00795
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.